Hayat,M.A., Ovarian Cancer. Methods of Cancer Diagnosis, Therapy, and Prognosis, 6, pp.5-9.

Transcription

1 DAFTAR PUSTAKA Bologna-Molina, R., Mosqueda-Taylor, A., Molina-Frechero, N., Mori-Estevez, A.D., Sánchez-Acuña G., Comparison of The Value of PCNA and Ki-67 as Markers of Cell Proliferation in Ameloblastic tumors. Medicina Oral, Patologia Oral y Cirugia Bucal, 18(2). Pp: e174- e179. Chen, V.W., Ruiz, B., Killeen, J.L., Coté, T.R., Wu, X.C., Correa, C.N., Pathology and Classification of Ovarian Tumors. Cancer, 97(10 Suppl), pp Davis, M. et al., Comparison of Clinical Outcomes of Patients with Clear Cell and Endometrioid Ovarian Cancer Associated with Endometriosis to Papillary Serous Carcinoma of The Ovary. Gynecologic Oncology, 132(3), pp De Azambuja, E. et al., Ki-67 as Prognostic Marker in Early Breast Cancer: A Meta-analysis of Published Studies Involving 12,155 Patients. British Journal of Cancer, 96(10), pp Funk, J.O., Waga, S., Harry, J.B., Espling, E., Stillman, B., Galloway, D., Inhibition of CDK Activity and PCNA-dependent DNA Replication p21 is Blocked by Interaction with The HPV-16 E7 Oncoprotein. Genes and Development, 11(16), pp Gadducci, A. et al., Serum and Tissue Biomarkers as Predictive and Prognostic Variables in Epithelial Ovarian Cancer. Critical Reviews in Oncology/Hematology, 69(1), pp Georgescu, C. V., Florescu, M., Simionescu, C., Value of Immunohistochemistry in Confirming Undifferentiated Ovarian Carcinomas. Romanian Journal of Morphology and Embryology = Revue Roumaine de Morphologie et Embryologie, 45, pp

2 Giurgea, L.N., Ungureanu, C., Mihailovici, M.S., The Immunohistochemical Expression of p53 and Ki67 in Ovarian Epithelial Borderline Tumors. Correlation with Clinicopathological Factors. Romanian Journal of Morphology and Embryology, 53(4), pp Guzińska-Ustymowicz, K., Pryczynicz, A., Kemona, A., Czyzewska, J., Correlation Between Proliferation Markers: PCNA, Ki-67, MCM-2 and Antiapoptotic Protein Bcl-2 in Colorectal Cancer. Anticancer Research, 29(8), pp Hamilton, W., Peters, T.J., Bankhead, C., Sharp, D., Risk of Ovarian Cancer in Women with Symptoms in Primary Care: Population Based Case-control Study. BMJ (Clinical research ed.), 339, pp.b2998. Hayat,M.A., Ovarian Cancer. Methods of Cancer Diagnosis, Therapy, and Prognosis, 6, pp.5-9. Jonat, W. & Arnold, N., Is the Ki-67 Labelling Index Ready for Clinical Use? Annals of Oncology, 22(3), pp Jones, R.L. et al., The Prognostic Significance of Ki67 Before and After Neoadjuvant Chemotherapy in Breast Cancer. Breast Cancer Research and Treatment, 116(1), pp Junquiera, L.C., Caeneiro, J Basic Histology Text and Atlas. McGraw Hill. United States. Karuppayil, S.M., Moran, E., Gokul, M., Differential Regulation of p53-dependent and - independent Proliferating Cell Nuclear Antigen Gene Transcription by 12 S E1A Oncoprotein Requires CBP. The Jurnal of Biological Chemistry, 273(28), pp Klintman, M., Bendahl, P.O., Grabau, D., Lövgren, K., Malmström, P., Fernö, M., The Prognostic Value of Ki67 is Dependent on Estrogen Receptor Status and Histological Grade in Premenopausal Patients with 57

3 Node-negative Breast Cancer. Modern pathology: An Official Journal of The United States and Canadian Academy of Pathology, Inc, 23(2), pp Köbel, M. et al., Ovarian Carcinoma Subtypes are Different Diseases: Implications for Biomarker Studies. PLoS Medicine, 5(12), pp Komiyama, S.I., Aoki, D., Katsuki, Y., Nozawa, S., Proliferative Activity of Early Ovarian Clear Cell Adenocarcinoma Depends On Association with Endometriosis. European Journal of Obstetrics Gynecology and Reproductive Biology, 127(1), pp Korkolopoulou, P., Oates, J., Kittas, C., Crocker, J., p53, c-myc p62 and Proliferating Cell Nuclear Antigen (PCNA) Expression in Non-Hodgkin's Lymphomas. Journal of Clinical Pathology, 47, pp Kumar, V., Abbas, A. K., Aster J. C., Female Genital System and Breast. Robbins and Cotran Pathologic Basic of Disease. 9 edn. Elsevier Saunder, Philadelphia, pp Kurman, R. & Shih, I., The Origin and Pathogenesis of Epithelial Ovarian Cancer- A Proposed Unifying Theory. The American Journal of Surgical Pathology, 34(3), pp Levanon, K., Crum, C., Drapkin, R., New Insights Into The Pathogenesis of Serous Ovarian Cancer and Its Clinical Impact. Journal of Clinical Oncology, 26(32), pp Le Page, C., Huntsman, D.G., Provencher, D.M., Mes- Masson, A.M., Predictive and Prognostic Protein Biomarkers in Epithelial Ovarian Cancer: Recommendation for Future Studies. Cancers, 2(2), pp Luporsi, E. et al., Ki-67: Level of Evidence and Methodological Considerations for Its Role in The 58

4 Clinical Management of Breast Cancer: Analytical and Critical Review. Breast Cancer Research and Treatment, 132(3), pp Oemiati, R., Rahajeng, E. & Kristanto, A.Y., Prevalensi Tumor dan Beberapa Faktor yang Mempengaruhinya di Indonesia. Buletin Penelitian Kesehatan, 39(4), pp Paunesku, T. et al., Proliferating Cell Nuclear Antigen (PCNA): Ringmaster of The Genome. International journal of radiation biology, 77(10), pp Pectasides, D., Pectasides, E., Psyrri, A., Economopoulos, T., Treatment Issues in Clear Cell Carcinoma of The Ovary: A Different Entity? Oncologist, 11(10), pp Reitmaier, M., Rudlowski, C., Biesterfeld S., Rath, W., Schröder, W., 2000.[Comparative Studies on The Biological Significance of The Marker for Proliferation Ki-67-Antigen and PCNA in Primary Ovarian Carcinoma]. Zentralbl Gynakol, 122(7), pp Rubin, E. et al., The Female Reproductive System. Essentials of Rubin s Pathology. 6 edn. Lippincott Williams & Wilkins, Philadelphia, pp Sajeevan, T. et al., Immunohistochemical Study of p53 and Proliferating Cell Nuclear Antigen Expression in Odontogenic Keratocyst and Periapical Cyst. Journal of Pharmacy and Bioallied Sciences, 6(5), p.52. Siegel, R., Naishadham, D. & Jemal, A., Cancer Statistics, CA: A Cancer Journal for Clinicians, 62(1), pp Tan, D.S.P. & Kaye, S., Ovarian Clear Cell Adenocarcinoma: A Continuing Enigma. Journal of clinical pathology, 60(4), pp

5 Thomas, H. et al., Proliferating Cell Nuclear Antigen (PCNA) Immunostaining-A Prognostic Factor in Ovarian Cancer? British journal of cancer, 71(2), pp Tortora, G. J., & Derrickson, B.H., The Reproductive Systems. Principle Anatomy and Physiology. 13 edn. John Wiley&Sons, Asia, pp Widagdo, R., Angka Harapan Hidup Penerita Kanker Ovarium Rumah Sakit Sardjito. Bagian Obstetri dan Ginekologi FK UGM, Yogyakarta. Yerushalmi, R., Woods, R., Ravdin, P.M., Hayes, M.M., Gelmon, K., Ki67 in Breast Cancer: Prognostic and Predictive Potential. The Lancet Oncology, 11(2), pp Zhong, W. et al., Ki-67 and PCNA Expression in Prostate Cancer and Benign Prostatic Hyperplasia. Clinical and investigative medicine. Medecine clinique et experimentale, 31(1), pp.e8 E15. 60